Cheche Group Receives Nasdaq Noncompliance Notice on Minimum Bid Price-February 2024-www.financetom.com

Cheche Group Receives Nasdaq Noncompliance Notice on Minimum Bid Price

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Cheche Group Receives Nasdaq Noncompliance Notice on Minimum Bid Price

Jun 10, 2025 2:37 PM

05:00 PM EDT, 06/10/2025 (MT Newswires) -- Cheche Group ( CCG ) received a noncompliance notice from Nasdaq after its Class A shares traded below the $1 minimum bid price requirement for 31 straight business days.

The notice doesn't immediately impact the stock listing or trading on Nasdaq, Cheche ( CCG ) said Tuesday in a statement.

The company has until Dec. 2 to regain compliance by maintaining a closing bid price of at least $1 for 10 consecutive business days.

Previous page： Market Chatter: Walt Disney, Fox, Warner Bros. to Appeal Ruling That Halted Venu Sports Launch Next page： Algernon Pharmaceuticals Receives U.S. Patent for Repirinast

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Market Chatter: Walt Disney, Fox, Warner Bros. to Appeal Ruling That Halted Venu Sports Launch

Jan 6, 2025

08:27 AM EST, 01/06/2025 (MT Newswires) -- Walt Disney ( DIS ) , Fox (FOX), and Warner Bros Discovery ( WBD ) will urge the US Court of Appeals to reverse a ruling made by a lower court that halted the launch of their Venu Sports streaming service, Reuters reported Monday citing a legal filing. An injunction was issued by...

Algernon Pharmaceuticals Receives U.S. Patent for Repirinast

Jan 6, 2025

08:20 AM EST, 01/06/2025 (MT Newswires) -- Algernon Pharmaceuticals ( AGNPF ) on Monday said it received a notice of allowance from the United States Patent and Trademark Office for Repirinast, the company's lead chronic kidney disease (CKD) drug. The company has corresponding patents in Japan and China and has applications pending in Europe and Canada. Repirinast is Algernon's lead...

Tilray Edges Up in U.S. Pre-Market After Winning Tender to Supply Luxembourg With Medical Cannabis

Jan 6, 2025

08:23 AM EST, 01/06/2025 (MT Newswires) -- Tilray Brands ( TLRY ) rose 1% in U.S. pre-market trading on Monday after its German unit, Tilray Deutschland, won a contract to supply Luxembourg with high-quality cannabis flower. The U.S.-listed shares were last seen trading pre-market at $1.47. Shares of Tilray closed flat at $2.09 on Friday on the Toronto Stock Exchange....

Serve Robotics Raises $86 Million in Funding in December; Shares Rise Pre-Bell

Jan 6, 2025

08:27 AM EST, 01/06/2025 (MT Newswires) -- Serve Robotics ( SERV ) said Monday it had raised $86 million in gross proceeds in December, bringing its gross proceeds raised for the year to $167 million. The additional funding was raised through a previously filed ATM facility and the exercise of certain warrants. The funding is expected to significantly strengthen the...